Search PubMed⌕ Search

Biomedical subjects

B T Butcher

Publications and source records attributed to B T Butcher.

At least 55 records · Page 3Linked to original sources
PubMed1982

Five-year longitudinal study of workers employed in a new toluene diisocyanate manufacturing plant.

The respiratory health of 277 workers in a new toluene diisocyanate (TDI) manufacturing plant was studied prospectively during 5 yr of exposure. Personal TDI monitors were used to continuously measure peak and 8-h time-weighted average (TWA) concentrations in over 2,000 samples. Longitudinal change in pulmonary function was assessed in 223 men in whom 3 or more data points allowed construction of individual slopes of annual change. Regression of annual change on smoking (pack-years), atopic status, and cumulative TDI exposure dichotomized at 68.2 parts per billion (ppb) months into low and high exposure groups showed significant effects of smoking on spirometric tests and lung volumes. After adjusting for pack-years of smoking, the 74 men in the high cumulative TDI exposure category had significantly larger declines in FEV1, %FEV, and FEF25--75% than did the 149 men in the low category. Annual change in FEV1 was then examined in 6 smoking-exposure categories: in never smokers, average annual decline was 38 ml/yr greater in those with higher cumulative TDI exposure. Current and previous cigarette smokers did not show this effect of cumulative TDI exposure. Analysis of FEV1 change by time above 20 ppb TDI yielded a similar result in never smokers, a 24 ml/yr excess average decline attributable to longer time above 20 ppb. In current cigarette smokers, those with longer time above 20 ppb had excess decline of 18 ml/yr (42 versus 24 ml/yr). our low and high cumulative exposure groups spent 2 and 15%, respectively, of their working time above 5 ppb TDI. The different health effects observed in these groups supports the NIOSH-recommended standard of 5 ppb TDI as an 8-h TWA.

Adult↗
PubMed1981

An approach to fungal antigen relationships by radioallergosorbent test inhibition.

Antigenic relationships among three species of Aspergillus (A. fumigatus, A. glaucus, and A. flavus) were examined by paired cross-radioallergosorbent test (RAST) inhibition analysis, an in vitro technique based on human IgE antibody specificity. Alternaria tenuis was found to be antigenically unrelated to each of the three species of Aspergillus and was used as a negative control. A single test serum yielded uninhibited RAST indices of 6, 7.4, 8.1, and 7.8 for A. fumigatus, A. glaucus, A. flavus, and Alternaria tenuis, respectively. At a concentration of 10 mg/ml, A. fumigatus inhibited A. glaucus RAST by 63% and A. flavus RAST by 62%. A. glaucus inhibited A. fumigatus RAST by 36% and A. flavus RAST by 63%. A. flavus inhibited A. fumigatus RAST by 44% and A. glaucus RAST by 81%. Each species of Aspergillus produced significant but only partial inhibition of RAST to each of the other two species analyzed. Results indicate the existence of both shared and unique antigens among these three species of Aspergillus. Paired cross-RAST inhibition may be used as an approach to study species relationships among genera of several classes of clinically relevant fungi. Unless many strains are employed, data obtained do not represent a definitive analysis of species, because of possible different degrees of inhibition by various strains of a particular species. They do, however, allow for the antigenic comparison of two or more crude, poorly characterized preparations thought to be important in human allergic disease.

Antibodies↗
PubMed1980

Radioallergosorbent testing of toluene diisocyanate-reactive individuals using p-tolyl isocyanate antigen.

Serum from 26 persons shown to react to provocative inhalation challenge with low concentration of toluene diisocyanate (TDI) was tested by radioallergosorbent test (RAST) using a p-tolyl isocyanate-human serum albumin (TMI-HSA) conjugate. Results were evaluated by the RAST ratio and by the mean +3 standard deviation methods. Positive results were obtained in 15% to 19% of TDI reactors, depending on the method of evaluation. These findings suggest that TDI asthma may be a complex syndrome with several types of reaction possible, including an IgE mechanism in some individuals, but they do not support the theory that TDI asthma is based solely on an immune mechanism. However, they do not disagree with the hypothesis that TDI reactivity may be mediated by a pharmacologic mechanism.

Antigens↗
PubMed1980

Interaction of atopy and exposure to cotton dust in the bronchoconstrictor response.

A survey of 255 workers in four cottonseed crushing mills included a respiratory health questionnaire, allergy skin testing, and measurements of lung function over the Monday working shift. Atopy was defined as having two or more positive weal reactions to common inhalant antigens. Categories of exposure to dust were based on the stage of milling, and one category contained workers with continuous exposure to cotton dust derived from linters, the cotton fibres adherent to cottonseed. Atopy and exposure to dust were found to have significant interaction: large mean declines in FEV1 and FEF 25-75 occurred only in the workers exposed to linter dust who were also atopic. Skin-testing surveys in cotton textile mills have concentrated on specific cotton antigen reactivity and its first-order relations to symptoms. Our results indicate a need to identify atopic workers, and to search for interactions between atopy and other variables that may influence acute changes in expiratory flow rates.

Adult↗
PubMed1979

Inhalation challenge and pharmacologic studies of toluene diisocyanate (TDI)-sensitive workers.

Workers with "sensitivity" to toluene diisocyanate (TDI) studied in depth in an attempt to determine mechanisms of bronchial hyperreactivity. Tests included provocative inhalation challenge (PIC) with TDI and methacholine challenge. Blood samples obtained prior to and at various times after PIC were used to measure complement and split products of complement and plasma histamine levels and to determine dose-response slopes of lymphocyte cyclic adenosine monophosphate (cAMP) following stimulation with agonists. TDI-reactive individuals were all reactive to methacholine and responded to PIC with TDI by immediate, delayed, or dual bronchospastic reactions. No change in plasma histamine, total complement levels, or split products of complement were measurable. TDI reactors gave decreased lymphocyte cAMP dose response slopes to stimulation with isoproterenol, prostaglandin E1, and TDI, which suggests that impairment of adrenergic receptors may play an important role in TDI reactivity.

Aerosols↗
PubMed1977

The in vitro effect of toluene diisocyanate on lymphocyte cyclic adenosine monophosphate production by isoproterenol, prostaglandin, and histamine: a possible mode of action.

Toluene diisocyanate (TDI) significantly inhibits the rise in intracellular cyclic 3',5'-adenosine monophosphate (cAMP) that follows in vitro incubation of human lymphocytes with 6.7 x 10(-3) M isoproterenol and 1 x 10(-6) M prostagladin E1 (p less than 0.05). TDI has no significant effect on th production of lymphocyte cAMP following incubation with histamine (1 x 10(-3) M). The inhibitory action of TDI is greatest at a concentration of 3.3 x 10(-4) M and diminishes as the TDI concentration is increased or decreased. TDI also caused four- to fivefold stimulation of lymphocyte cAMP, an effect that is maximal at 1 x 10(-3) M, a concentration which has no significant inhibitory effect on stimulation of cAMP by isoproterenol or prostagladin E1. Conversely, 3.3 x 10(-4) M TDI, which inhibits cAMP production by isoproterenol and prostaglandin, has little stimulatory effect itself on cAMP production. This evidence suggests that TDI might induce obstructive airways disease through pharmacologic mechanisms and that TDI may be acting as a partial agonist.

Asthma↗